Jason Grebely

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Natasha K. Martin, Peter Vickerman, Jason Grebely et al. · Hepatology · 2013 · 502 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +15

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

Soumitri Barua, Robert A. Greenwald, Jason Grebely et al. · Annals of Internal Medicine · 2015 · 397 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

Jason Grebely, Kimberly Page, Rachel Sacks‐Davis et al. · Hepatology · 2013 · 396 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

Gregory J. Dore, Frederick L. Altice, Alain H. Litwin et al. · Annals of Internal Medicine · 2016 · 363 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely, Olav Dalgård, Brian Conway et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 292 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14